Cibc Bancorp Usa Inc. Astrazeneca PLC Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 8,164,278 shares of AZN stock, worth $723 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
8,164,278Holding current value
$723 Million% of portfolio
0.77%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,465Shares Held
502MCall Options Held
7.13MPut Options Held
2.67M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.6 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.53 Billion2.42% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$3.04 Billion0.45% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.76 Billion0.16% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.22 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $275B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...